BioTech Medics, Inc., Enters LOI With Nutriceutical Co. Harwood Enterprises, LP

DALLAS, Feb. 7  /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD) has entered into a Letter of Intent to acquire specified BioBody Product formula, trademarks and copyrights of Harwood Enterprises Worldwide, LP.

Keith Houser, CEO, stated, "As a part of our pledge to increase the value of BTMD, BioTech Medics Wellness program, we want to offer some of the best nutriceutical health products available to our clientele.  Harwood has over a half dozen proven products which complement our goals and objectives of wellness.  Harwood also brings the expertise and knowledge to help BTMD to finish developing our exclusive and patented SHBAN products."

Harwood is an eight-year-old Texas company that offers proprietary ingredient patented products which help the body to function at its best. The main line product is BioBody Balance(TM). The line of Harwood Products are featured on the web at http://www.uniqueformulas.com/ .  Harwood has had Gross Revenues of $1.5 million annually for the past 3 years aggregating Combined Gross Revenues of $4.5 million.  The stock acquisition is estimated to be valued at $5 million.  Closing is to take place on or before March 3, 2006.

BioTech Medics is a distributor of the NeuroLase Therapeutic Medical Laser. The NeuroLase provides relief from muscular, skeletal and arthritic pain.  BTMD operates a Pain Management & Wellness Center in Dallas with Charles R. Crane, MD.  BTMD plans on closing on more new Pain Management & Wellness Centers in 2006, as well as acquiring a permanent office building in Dallas, Texas.

BioTech pledges to strive to add more assets and increased revenue for the company to bring more value to the stock and its more than 5,800 shareholders in 22 countries.

   Contact:  BioTech Medics, Inc., at 972-274-5533

  Check BTMD Out On the Web at http://www.biotechmedics.com/

  Safe Harbor for Forward-Looking Statements


This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "confident that," "believe," "scheduled," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. 

DATASOURCE: BioTech Medics, Inc.



CONTACT:  BioTech Medics, Inc., [phone]



Web site:  http://www.biotechmedics.com/

http://www.uniqueformulas.com/ 

Copyright